Xembify Product Launch

In Fall 2019, I lead an exciting new product launch: Xembify. It is for the subcutaneous treatment of primary immunodeficiency (PIDD). It is a 20% immune globulin solution.

Because PIDD patients lack IgG antibodies, they are more susceptible to germs that cause infections. They naturally tend to avoid being outside and in public. Our Xembify campaign depicts patients being happy and active and with other people in public spaces because they are protected by Xembify’s “Y” aura, a reference to the antibody molecule structure (commonly understood by HCPs).

For this launch, I developed Xembify's identity, branding, multi-image HCP marketing campaign, website, sales aid materials, corporate sales meeting design, and more.

The market research proved this campaign has been well received by HCPs.

Client Name: Grifols

Category: Product Launch